Total Payments
$729,129
2024 Payments
$1,620
Companies
58
Transactions
2,213
Medicare Patients
8,987
Medicare Billing
$433,687
Payment Breakdown by Category
Other$614,769 (84.3%)
Travel$55,543 (7.6%)
Food & Beverage$37,798 (5.2%)
Consulting$20,990 (2.9%)
Education$29.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $602,596 | 454 | 82.6% |
| Travel and Lodging | $55,543 | 167 | 7.6% |
| Food and Beverage | $37,798 | 1,567 | 5.2% |
| Consulting Fee | $20,990 | 14 | 2.9% |
| Honoraria | $9,875 | 5 | 1.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,298 | 1 | 0.3% |
| Education | $29.13 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $250,437 | 705 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171,334 | 368 | $0 (2024) |
| Novo Nordisk Inc | $92,857 | 258 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $90,188 | 168 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $57,741 | 121 | $0 (2020) |
| Dexcom, Inc. | $31,128 | 62 | $0 (2024) |
| ABBVIE INC. | $16,242 | 67 | $0 (2024) |
| Senseonics, Incorporated | $4,000 | 1 | $0 (2023) |
| Corcept Therapeutics | $3,738 | 31 | $0 (2024) |
| Ascensia Diabetes Care Us Inc. | $2,669 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,620 | 87 | Xeris Pharmaceuticals, Inc. ($211.01) |
| 2023 | $30,879 | 169 | Lilly USA, LLC ($12,461) |
| 2022 | $141,998 | 329 | Lilly USA, LLC ($59,651) |
| 2021 | $84,743 | 276 | SANOFI-AVENTIS U.S. LLC ($28,406) |
| 2020 | $122,193 | 285 | Lilly USA, LLC ($39,490) |
| 2019 | $246,627 | 577 | Lilly USA, LLC ($126,366) |
| 2018 | $99,581 | 407 | Boehringer Ingelheim Pharmaceuticals, Inc. ($70,584) |
| 2017 | $1,488 | 83 | Lilly USA, LLC ($445.37) |
All Payment Transactions
2,213 individual payment records from CMS Open Payments — Page 1 of 89
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Biological | ||||||
| 12/04/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Hyperthyroidism | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: ACROMEGALY | ||||||
| 09/20/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/10/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Bone Health | ||||||
| 08/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 08/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,876 | 4,227 | $447,005 | $115,012 |
| 2022 | 46 | 3,185 | 4,254 | $550,777 | $136,675 |
| 2021 | 37 | 2,070 | 2,827 | $380,628 | $107,727 |
| 2020 | 14 | 856 | 1,394 | $233,212 | $74,274 |
Total Patients
8,987
Total Services
12,702
Medicare Billing
$433,687
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 375 | $93,750 | $30,710 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 79 | 96 | $33,120 | $12,534 | 37.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 241 | 382 | $30,178 | $6,256 | 20.7% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 144 | 225 | $21,150 | $6,161 | 29.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 146 | 236 | $21,948 | $5,947 | 27.1% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 207 | 349 | $22,685 | $5,793 | 25.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 157 | 178 | $26,700 | $5,135 | 19.2% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 136 | 210 | $15,750 | $4,452 | 28.3% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2023 | 142 | 221 | $19,448 | $4,006 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $10,625 | $3,920 | 36.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 220 | 310 | $17,050 | $3,198 | 18.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 54 | 60 | $22,800 | $3,187 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,750 | $3,153 | 32.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 207 | 350 | $19,600 | $3,082 | 15.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 44 | 118 | $11,220 | $2,917 | 26.0% |
| 84144 | Progesterone (reproductive hormone) level | Office | 2023 | 92 | 122 | $8,296 | $2,473 | 29.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 184 | 260 | $10,400 | $1,979 | 19.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 111 | 198 | $10,296 | $1,818 | 17.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 95 | 100 | $8,100 | $1,463 | 18.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 75 | 77 | $4,928 | $1,010 | 20.5% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 12 | 12 | $4,080 | $974.74 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,450 | $792.37 | 32.3% |
| 86376 | Microsomal antibodies (autoantibody) measurement | Office | 2023 | 53 | 53 | $4,346 | $755.78 | 17.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 47 | 50 | $3,700 | $654.64 | 17.7% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 11 | 11 | $3,300 | $634.92 | 19.2% |
About Dr. Cassie Smith, MD
Dr. Cassie Smith, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Edmond, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1578852703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cassie Smith, MD has received a total of $729,129 in payments from pharmaceutical and medical device companies, with $1,620 received in 2024. These payments were reported across 2,213 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($602,596).
As a Medicare-enrolled provider, Smith has provided services to 8,987 Medicare beneficiaries, totaling 12,702 services with total Medicare billing of $433,687. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Edmond, OK
- Active Since 03/28/2011
- Last Updated 06/16/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1578852703
Products in Payments
- JARDIANCE (Drug) $226,727
- TRULICITY (Drug) $112,967
- INVOKANA (Drug) $57,502
- MOUNJARO (Drug) $50,114
- Ozempic (Drug) $47,796
- SOLIQUA 100/33 (Biological) $36,443
- TOUJEO (Drug) $25,341
- RYBELSUS (Drug) $22,341
- Rybelsus (Drug) $18,876
- TOUJEO (Biological) $15,411
- Dexcom CGM (Device) $11,148
- DEXCOM G6 TRANSMITTER (Device) $10,681
- SYNTHROID (Drug) $10,369
- DEXCOM G6 CGM SYSTEM (Device) $6,610
- Synthroid (Drug) $5,405
- SOLIQUA 100/33 (Drug) $5,214
- SOLIQUA (Drug) $4,656
- Eversense (Device) $4,000
- Korlym (Drug) $3,738
- DISEASE STATE (Drug) $3,035
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.